Publications
484 publications
- Date
- Relevance
-
Onabotulinum toxin A 100 U in cases of idiopathic overactive bladder
The National Health Care Institute concluded that treatment with onabotulin toxin A 100 U does comply with the established ...
-
Ivermectin (Soolantra®) by moderate to severe papulopustulous rosacea
The National Health Care Institute advises the Minister of Public Health, Welfare and Sport to include ivermectin (Soolantra®) in ...
-
Eltrombopag (Revolade®) in cases of severe aplastic anaemia
The National Health Care Institute has approved a pharmacotherapeutic report for the medicine eltrombopag (Revolade®) in cases of ...
-
Health care in the Netherlands
The philosophy underpinning the Dutch health care system is based on several more or less universal principles: access to care ...
-
Tolvaptan (Jinarc) by cyst development and renal insufficiency of autosomal dominant polycystic kidney disease (ADPKD)
Based on the criteria for mutual replaceability, tolvaptan is not eligible for placing on List 1A of the GVS. Nor is tolvaptan ...
-
Cost-effectiveness in practice
Cost-effectiveness is one criterion that helps us to make responsible choices. It gives us insight into how much “value we are ...
-
Zinnige Zorg - Systematic Analysis of neoplasms
The National Health Care Institute published this report within the context of a systematic examination of the insured package.1 ...
-
Moving towards new health care and new health care professions (the contours)
This report is a summary of recommendations by Zorginstituut Nederland. The original text is in Dutch.
-
Assessment of established medical science and medical practice
In this report we describe, ‘anno today’, how we assess the criterion ‘established medical science and medical practice‘ and ...
-
Taking care of good healthcare